Researchers have identified a group of natural compounds from a Brazilian tree that show promising activity against the virus responsible…
Read More
Brazilian Tree Compounds Show Potent Multi-Target Activity Against COVID-19 Virus
Researchers have identified a group of natural compounds from a Brazilian tree that show promising activity against the virus responsible…
Read More
Indiana University Researchers Identify IDOL Enzyme as Novel Therapeutic Target for Alzheimer’s Disease Treatment and Neuroprotection
The global fight against Alzheimer’s disease has reached a critical juncture as researchers at the Indiana University School of Medicine…
Read More
HKUMed Researchers Identify Piezo1 Protein as the Key Exercise Sensor in Bone Maintenance and Potential Target for Osteoporosis Treatment
Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…
Read More
Brazilian Tree Compounds Show Potent Multi-Target Activity Against COVID-19 Virus
Researchers have identified a group of natural compounds from a Brazilian tree that show promising activity against the virus responsible…
Read More
Brazilian Tree Compounds Exhibit Potent Multi-Target Activity Against COVID-19 Virus
Researchers have identified a group of natural compounds derived from a Brazilian tree that demonstrate significant promise in combating the…
Read More
Johns Hopkins Researchers Identify Key Protein and Gas Signaling Pathway as Potential Target for Alzheimer’s Disease Treatment
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the understanding of Alzheimer’s disease, identifying a specific protein…
Read More
Hydrogen Sulfide and CSE Protein Research Offers New Therapeutic Target for Alzheimer’s Disease Treatment and Brain Health
Researchers at Johns Hopkins Medicine have announced that a newly funded study by the National Institutes of Health (NIH) is…
Read More
Johns Hopkins Researchers Identify Brain Protein Producing Hydrogen Sulfide as Potential Target for Alzheimer’s Treatment
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the quest to understand and eventually treat Alzheimer’s disease,…
Read More
Jeito Capital’s Second Fund Closes Above Target, Bolstering European Biopharma Investment to Over €1.6 Billion
Global independent private equity fund Jeito Capital has achieved a significant milestone in European biopharma investment with the successful closure…
Read MoreYOU MAY HAVE MISSED
